Boeing Reaches Tentative Labor Deal With SPEEA Workers After Spirit AeroSystems Acquisition 
U.S. Moves to Expand Chevron License and Control Venezuelan Oil Sales 
Renault Group Global Sales Rise 3.2% in 2025 on Strong International and EV Demand 
Pop Mart Shares Surge in Hong Kong After First Buyback in Nearly Two Years 
Toyota Industries Buyout Faces Resistance as Elliott Rejects Higher Offer 
Tesla Revives Dojo Supercomputer Project With AI5 Chip at the Core 
Publishers Seek to Join Lawsuit Against Google Over Alleged AI Copyright Infringement 
White House Pressures PJM to Act as Data Center Energy Demand Threatens Grid Reliability 
Syrah Resources and Tesla Extend Deadline on Graphite Supply Dispute to March 
Valentino Garavani Dies at 93, Leaving Behind the Timeless Legacy of Valentino Red 
China Halts Shipments of Nvidia H200 AI Chips, Forcing Suppliers to Pause Production 
Federal Judge Clears Way for Jury Trial in Elon Musk’s Fraud Lawsuit Against OpenAI and Microsoft 
Baidu Shares Rise in Hong Kong After Apollo Go Robotaxi Launch in Abu Dhabi 
TSMC Shares Hit Record High as AI Chip Demand Fuels Strong Q4 Earnings 
Jamie Dimon Signals Possible Five More Years as JPMorgan CEO Amid Ongoing Succession Speculation 
TikTok Expands AI Age-Detection Technology Across Europe Amid Rising Regulatory Pressure 
MALVERN, Pa., April 25, 2017 -- BioTelemetry, Inc. (NASDAQ:BEAT) will release its first quarter 2017 earnings on Wednesday, May 3, 2017 at 4:00 PM Eastern Time.
The BioTelemetry quarterly conference call will be held at 5:00 PM Eastern Time, Wednesday, May 3, 2017. The broadcast will be available through the investor information section of the BioTelemetry website at www.gobio.com. If you are unable to participate during the live webcast, an archive will be available on our website for two weeks.
About BioTelemetry
BioTelemetry, Inc., formerly known as CardioNet, Inc., is the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care. The Company currently provides cardiac monitoring services, original equipment manufacturing with a primary focus on cardiac monitoring devices and centralized core laboratory services. More information can be found at www.gobio.com.
Contact: BioTelemetry, Inc. Heather C. Getz Investor Relations 800-908-7103 [email protected]
